佩里c Siatis

Mr. Siatis began his career by practicing commercial and intellectual property (IP) litigation at DLA Piper LLP. He joined Abbott in 2005 as Counsel and progressed to Division Counsel, IP Litigation and later became Divisional Vice President and Section Head, IP Strategy. In January 2013, Mr. Siatis joined AbbVie where he served as Vice President, Biologic Strategic Development and Legal Regulatory where he strengthened the legal strategy surrounding AbbVie’s premier biologic and the world’s top selling drug. Prior to his most recent role, Mr. Siatis was the Senior Vice President of Legal Transactions and R&D/Alliance Management and Chief Ethics and Compliance Officer.

Mr. Siatis is a champion of diversity and inclusion and has spearheaded AbbVie Legal engagements with Historically Black Colleges and Universities and the National Association of Minority & Women Owned Law Firms. At AbbVie, he is the executive sponsor of the ABILITY Employee Resource Group.  

Mr. Siatis earned a bachelor's degree in accounting from George Mason University and a Juris Doctorate degree from Brigham Young University.

佩里Siatis是执行副总裁、总法律顾问和秘书,行政领导团队的成员,负责全球法律和道德与合规的办公室。他擅长谈判非常成功的全球商业交易,导航复杂的政府政策,提供战略法律指导多个数十亿美元的品牌。2020年,他领导收购的法律策略爱力根,医药历史上最大的收购之一。

Siatis先生开始他的职业生涯通过练习商业和知识产权(IP)在欧华律师事务所律师事务所诉讼。他于2005年加入雅培顾问顾问和发展部门,知识产权诉讼和后来成为部门副总裁和部分头,知识产权战略。Siatis先生,2013年1月加入AbbVie他担任副总统,生物战略发展和法律监管,加强了法律策略围绕AbbVie首屈一指的生物和世界的最畅销的药物。狗万正网地址他最近的角色之前,Siatis先生是法律事务的高级副总裁和研发管理和道德与合规总监/联盟。

Siatis先生是一个冠军的多样性和包容性,牵头AbbVie法律与传统黑人学院和大学活动和协会的少数民族和妇女拥有的律师事务所。在AbbVie,他的高层执行官员工资源组的能力。

Siatis先生赢得了乔治梅森大学会计学士学位和法学杨百翰大学的博士学位。